Scaffold identification of a new class of potent and selective BCRP inhibitors

ChemMedChem
Federico MarighettiMichael Wiese

Abstract

We recently reported the synthesis and quantitative structure-activity relationships of a new breast cancer resistance protein (BCRP) inhibitor class. In the study presented herein, we investigated the possibility to better define the scaffold of this compound class by removing or modifying the aromatic ring A with various substituents selected on the basis of their electronic and lipophilic properties. The results show that this aromatic ring is important, but not essential, for activity. Many of the selected substituents led to compounds with low activity, but in some cases activity was retained. Among these, a phenolic hydroxy group proved to impart as much potency to the molecule as a hydroxyethyl side chain, initially considered necessary for activity. This derivative is one of the most active compounds in this class, maintaining an inhibitory activity similar to that of the reference compound; it is also selective for BCRP.

References

Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Oct 9, 2002·Current Protein & Peptide Science·Karin F K Ejendal, Christine A Hrycyna
Nov 15, 2002·Cancer Biology & Therapy·W Stratford May, Peter P Ruvolo
Nov 18, 2003·International Journal of Cancer. Journal International Du Cancer·Ken ShiozawaShigeru Kohno
Apr 23, 2004·Molecular Pharmacology·Shuzhong ZhangMarilyn E Morris
Feb 8, 2005·The International Journal of Biochemistry & Cell Biology·Frantisek Staud, Petr Pavek
Mar 8, 2006·Anti-cancer Drugs·Abdelhakim Ahmed-BelkacemAttilio Di Pietro
Sep 25, 2007·Bioorganic & Medicinal Chemistry·Henrik MüllerMichael Wiese
Dec 18, 2007·Bioorganic & Medicinal Chemistry·Henrik MüllerMichael Wiese
Feb 7, 2008·British Journal of Cancer·C LemosG J Peters
Aug 6, 2008·Bioorganic & Medicinal Chemistry·Anne PickMichael Wiese
Jan 3, 2009·Advanced Drug Delivery Reviews·Maria L H VlamingAlfred H Schinkel
Nov 26, 2009·Bioorganic & Medicinal Chemistry Letters·Anne PickMichael Wiese
Jul 16, 2010·ChemMedChem·Anne PickMichael Wiese
Mar 1, 2011·Bioorganic & Medicinal Chemistry·Anne PickMichael Wiese
Nov 25, 2011·Bioorganic & Medicinal Chemistry·Kapil JuvaleMichael Wiese
Sep 29, 2012·Bioorganic & Medicinal Chemistry Letters·Kapil Juvale, Michael Wiese
Nov 15, 2012·ChemMedChem·Federico MarighettiMichael Wiese
Jul 16, 2013·European Journal of Medicinal Chemistry·Kapil JuvaleMichael Wiese
Nov 5, 2013·Bioorganic & Medicinal Chemistry·Kapil JuvaleMichael Wiese

❮ Previous
Next ❯

Citations

Mar 5, 2016·Journal of Medicinal Chemistry·Sven Marcel SchmittMichael Wiese
Apr 10, 2015·Journal of Medicinal Chemistry·Sebastian C Köhler, Michael Wiese
Aug 5, 2018·Journal of Medicinal Chemistry·Michael K KrapfMichael Wiese

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.